Literature DB >> 15358203

Nek2A specifies the centrosomal localization of Erk2.

Yang Lou1, Wei Xie, Dong-Fang Zhang, Jian-hui Yao, Zhao-feng Luo, Yu-Zhen Wang, Yun-Yu Shi, Xue-Biao Yao.   

Abstract

Nek2A is a cell-cycle-regulated protein kinase that localizes to the centrosome and kinetochore. Our recent studies provide a link between Nek2A and spindle checkpoint signaling [J. Biol. Chem. 279 (2004) 20049]. Extracellular signal-regulated kinase 2 (Erk2) is an important kinase, which belongs to mitogen activating protein (MAP) kinase family. Here we demonstrated that Nek2A binds specifically to Erk2. Erk2 interacts with Nek2A via a conserved Erk2 docking site located to the C-terminus of Nek2A. Our studies indicate this docking site is essential and sufficient for a direct Nek2A-Erk2 interaction. In addition, our immunocytochemical studies show that Nek2A and Erk2 are co-localized to centrosome. Significantly, elimination of Nek2A by RNA interference delocalized Erk2 from its centrosomal location, while inhibition of Erk2 kinase activity did not affect the localization of Nek2A in centrosome. We propose that Erk2 links extracellular signaling to centrosome dynamics by Nek2A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358203     DOI: 10.1016/j.bbrc.2004.06.171

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Nek1 interacts with Ku80 to assist chromatin loading of replication factors and S-phase progression.

Authors:  Mallikarjun Patil; Navjotsingh Pabla; Han-Fei Ding; Zheng Dong
Journal:  Cell Cycle       Date:  2013-07-10       Impact factor: 4.534

2.  Mining the Giardia genome and proteome for conserved and unique basal body proteins.

Authors:  Tineke Lauwaet; Alias J Smith; David S Reiner; Edwin P Romijn; Catherine C L Wong; Barbara J Davids; Sheila A Shah; John R Yates; Frances D Gillin
Journal:  Int J Parasitol       Date:  2011-07-01       Impact factor: 3.981

Review 3.  "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases.

Authors:  Gabriela Vaz Meirelles; Arina Marina Perez; Edmárcia Elisa de Souza; Fernanda Luisa Basei; Priscila Ferreira Papa; Talita Diniz Melo Hanchuk; Vanessa Bomfim Cardoso; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2014-05-26

4.  Mitogen-activated protein kinase kinase 1-dependent Golgi unlinking occurs in G2 phase and promotes the G2/M cell cycle transition.

Authors:  Timothy N Feinstein; Adam D Linstedt
Journal:  Mol Biol Cell       Date:  2006-12-20       Impact factor: 4.138

5.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

6.  Mechanisms of aneuploidy induction by RAS and RAF oncogenes.

Authors:  Tamihiro Kamata; Catrin Pritchard
Journal:  Am J Cancer Res       Date:  2011-03-29       Impact factor: 6.166

7.  A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability.

Authors:  Bernardo Orr; Duane A Compton
Journal:  Front Oncol       Date:  2013-06-27       Impact factor: 6.244

8.  The MEK2-binding tumor suppressor hDlg is recruited by E-cadherin to the midbody ring.

Authors:  Suzanne Gaudet; Marie-Josée Langlois; Robert A Lue; Nathalie Rivard; Alain Viel
Journal:  BMC Cell Biol       Date:  2011-12-20       Impact factor: 4.241

9.  Nek family of kinases in cell cycle, checkpoint control and cancer.

Authors:  Larissa Moniz; Previn Dutt; Nasir Haider; Vuk Stambolic
Journal:  Cell Div       Date:  2011-10-31       Impact factor: 5.130

10.  Involvement of NEK2 and its interaction with NDC80 and CEP250 in hepatocellular carcinoma.

Authors:  Lu Zeng; Xiude Fan; Xiaoyun Wang; Huan Deng; Xiaoge Zhang; Kun Zhang; Shan He; Na Li; Qunying Han; Zhengwen Liu
Journal:  BMC Med Genomics       Date:  2020-10-27       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.